HRBR - Bragar Eagel & Squire P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Equinix Harbor Diversified and Altimmune and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Equinix (NASDAQ:EQIX), Harbor Diversified, Inc. (OTC:HRBR), and Altimmune, Inc. (NASDAQ:ALT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Equinix (NASDAQ:EQIX)
Class Period: May 3, 2019 - March 24, 2024
Lead Plaintiff Deadline: July 1, 2024
According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Equinix manipulated its financials to reduce operational expenses and boost Adjusted Funds From Operations ("AFFO"); (2) Equinix oversold power capacity and did not warn of the risks associated with this practice; (3) Equinix lacked adequate internal controls; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
For more information on the Equinix class action go to: https://bespc.com/cases/EQIX
Harbor Diversified, Inc. (OTC:HRBR)
Class Period: May 10, 2022 - March 29, 2024
Lead Plaintiff Deadline: July 8, 2024
According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Harbor Diversified's financial statements from May 9, 2022 to the present were misstated due to improper revenue recognition; (2) Harbor Diversified lacked adequate internal controls; and (3) as a result, defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.
For more information on the Harbor Diversified class action go to: https://bespc.com/cases/HRBR
Altimmune, Inc. (NASDAQ:ALT)
Class Period: December 1, 2023 - April 26, 2024
Lead Plaintiff Deadline: July 5, 2024